VIVS Stock Analysis: Buy, Sell, or Hold?

VIVS - VivoSim Labs, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.69
0.07 (4.32%) ▲
5d: +0.0%
30d: -9.63%
90d: -6.63%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 04, 2026 0d

Get Alerted When VIVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: VIVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: VIVS is currently trading at $1.69, which is considered slightly low relative to its 30-day fair value range of $1.61 to $2.01.

Technical Outlook: Technically, VIVS is in a downtrend. Immediate support is located at $1.25, while resistance sits at $1.79. The stock is showing strong short-term momentum, up 4.3% recently.

Market Sentiment: VIVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $1.61 - $2.01
Company Quality Score 40/100 (SELL)
Volume Confirmation HIGH
Confidence Score 58.8%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.3%)

Fair Price Analysis

30-Day Fair Range $1.61 - $2.01
Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $1.25
Resistance Level $1.79
Current Trend Downtrend
Technical data as of Apr 2, 2026

Fundamental Context

Revenue Growth (YoY) 8.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 05, 2026 5:02 PM ET
Data refreshes hourly during market hours. Next update: 6:02 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$25 53 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$411 52 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$111 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$8 53 HOLD
APLS
Apellis Pharmaceuticals …
BUY
22 analysts
$33 61 BUY

More Analysis for VIVS

VIVS Technical Chart VIVS Price Prediction VIVS Earnings Date VIVS Investment Advisor VIVS Fair Price Analyzer VIVS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals